Overview

• Haemanthus, founded by Billy Evans, aims to develop diagnostics using Raman spectroscopy and AI-guided light detection.
• The company has raised $3.5 million from family and friends and is seeking an additional $15 million toward a $50 million goal.
• Haemanthus plans to validate its technology through veterinary applications before exploring human diagnostics.
• The startup, which currently has 10–12 employees, has secured a patent for its Raman spectroscopy system.
• In a public statement, Haemanthus emphasized that Elizabeth Holmes has no involvement, rejecting comparisons to Theranos.